Share Price:

APNASPENAspen Pharmacare Hldgs2164312 (0.06%)
Our Response to Covid
Country Sites

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Regional Overviews

Aspen in Europe CIS

The Europe CIS region offers a diverse array of Sterile Focus and Regional Brands and engages in third‑party manufacturing. Within the revenue mix, the contribution from the Sterile Focus Brands portfolio ranks as the second highest, trailing behind Asia. This portfolio primarily includes Anaesthetics and, to a lesser extent, Thrombosis products in both Russia and the broader Europe CIS region. The manufacturing operations in this region encompass API and FDF production, are widely accredited and provide a variety of technologies for
Aspen’s own commercialisation strategy and for third-party use.

Key Countries

France
Germany
Ireland
Netherlands
Russian Federation

Overview

Learn More
Brand Therapeutic category

Emla

Local anaesthetic

Fraxiparine

Low molecular weight heparin

Ovestin

Estrogen hormone replacement

Ultiva

Injectable general anaesthetic

Xylocaine

Regional anaesthetic
Products
Launched

(2022: Nil)

0
Product
Recalls

(2022: 5)

0 %
Average Staff
Turnover

(2022: 9%)

Work-related
Facilities

(2022: Nil)

50
Sales
Representatives

(2022: 140)

900
Permanent
Employees

(June 2022: 2,192)

Revenue 2023
R’million		 2022 (CER)
R’million		 Change
%

Commercial Pharmaceuticals

4 847

5 206

(7)

Regional Brands

1 774

1 740

2

Sterile Focus Brands

3 073

3 466

(11)

Manufacturing

9 790

9 132

7

API

4 832

5 128

(6)

FDF - Steriles

1 037

1 007

3

FDF - Other

498

414

20

Heparin

3 423

2 583

33
Total

14 637

14 338

2

Note: Commercial Pharmaceuticals revenue is by customer geography and manufacturing revenue by place of manufacture.

Contribution to Group revenue (%)
  • Rest of Group 64
  • Europe CIS 36
Revenue by segment (%)
  • Manufacturing - API Chemicals 33
  • Manufacturing - FDF 10
  • Sterile Focus Brands 21
  • Regional Brands 12
  • Manufacturing - Heparin 24

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600

Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.